These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15857159)

  • 1. Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients.
    Javorský M; Kozárová M; Salagovic J; Tkáč I
    Physiol Res; 2006; 55(1):55-62. PubMed ID: 15857159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus.
    Tkác I; Salagovic J; Kozárová M; Javorský M; Tkácová R; Kalina I
    Wien Klin Wochenschr; 2003 Dec; 115(23):835-9. PubMed ID: 14740347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.
    Peacock RE; Hamsten A; Nilsson-Ehle P; Humphries SE
    Atherosclerosis; 1992 Dec; 97(2-3):171-85. PubMed ID: 1466662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PvuII polymorphism in the lipoprotein lipase gene with the coronary artery disease in Macedonian population.
    Georgiev A; Panov S; Sadikario S
    Prilozi; 2008 Dec; 29(2):213-25. PubMed ID: 19259048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.
    Bozina T; Simić I; Lovrić J; Pećin I; Jelaković B; Sertić J; Reiner Z
    Coll Antropol; 2013 Sep; 37(3):801-8. PubMed ID: 24308220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of lipoprotein lipase (LPL) polymorphism on plasma LPL concentration and triglyceride].
    Liu J; Zhao D; Liu J; Liu S; Qin LP; Wu ZS
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1339-43. PubMed ID: 16029634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease.
    Javorský M; Gasperíková D; Ukropec J; Sedláková B; Riecanský I; Krizanová O; Seböková E; Dobríková M; Klimes I; Tkác I
    Wien Klin Wochenschr; 2007; 119(15-16):476-82. PubMed ID: 17721767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes.
    Mattu RK; Trevelyan J; Needham EW; Khan M; Adiseshiah MA; Richter D; Murray RG; Betteridge DJ
    Diabetologia; 2002 Jun; 45(6):905-13. PubMed ID: 12107736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
    Ukkola O; Savolainen MJ; Salmela PI; von Dickhoff K; Kesäniemi YA
    Atherosclerosis; 1995 May; 115(1):99-105. PubMed ID: 7669092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women.
    Nicklas BJ; Ferrell RE; Rogus EM; Berman DM; Ryan AS; Dennis KE; Goldberg AP
    Hum Genet; 2000 Apr; 106(4):420-4. PubMed ID: 10830909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase gene polymorphisms and risks of childhood obesity in Chinese preschool children.
    Wang LN; Yu Q; Xiong Y; Liu LF; Zhang Z; Zhang XN; Cheng H; Wang B
    Eur J Pediatr; 2011 Oct; 170(10):1309-16. PubMed ID: 21431783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA polymorphisms of the lipoprotein lipase gene and their association with coronary artery disease in the Saudi population.
    Al-Jafari AA; Daoud MS; Mobeirek AF; Al Anazi MS
    Int J Mol Sci; 2012; 13(6):7559-7574. PubMed ID: 22837712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gene-diet interaction, LPL PvuII and HindIII and carbohydrate, on the criteria of metabolic syndrome: KMSRI-Seoul Study.
    Kim Y; Lee M; Lim Y; Jang Y; Park HK; Lee Y
    Nutrition; 2013 Sep; 29(9):1115-21. PubMed ID: 23927945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. . Association of HindIII and PvuII genetic polymorphisms of lipoprotein lipase with lipid metabolism and macrovascular events in type 2 diabetic patients.
    Socquard E; Durlach A; Clavel C; Nazeyrollas P; Durlach V
    Diabetes Metab; 2006 Jun; 32(3):262-9. PubMed ID: 16799404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus.
    Bruno G; Cavallo-Perin P; Bargero G; Borra M; D'Errico N; Pagano G
    Ann Intern Med; 1996 Oct; 125(8):653-7. PubMed ID: 8849150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease.
    Ahn YI; Kamboh MI; Hamman RF; Cole SA; Ferrell RE
    J Lipid Res; 1993 Mar; 34(3):421-8. PubMed ID: 8096867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease.
    Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Dak E; Cağatay P; Günay D; Büyükdevrim AS
    Arch Pathol Lab Med; 2004 Aug; 128(8):869-74. PubMed ID: 15270617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides.
    Mitchell RJ; Earl L; Bray P; Fripp YJ; Williams J
    Hum Biol; 1994 Jun; 66(3):383-97. PubMed ID: 8026810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.
    Lengyel Z; Vörös P; Tóth LK; Németh C; Kammerer L; Mihály M; Tornóci L; Rosivall L
    Wien Klin Wochenschr; 2004 Apr; 116(7-8):240-5. PubMed ID: 15143863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
    Jamshidi Y; Flavell DM; Hawe E; MacCallum PK; Meade TW; Humphries SE
    Atherosclerosis; 2002 Jul; 163(1):183-92. PubMed ID: 12048138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.